Amplify Lithium & Battery Technology ETF : BATT

BATT

Stock Data

$16.92

$0.04 (0.24%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

All BATT Articles

2 Articles

Michael Williams | Mar 25, 2026 at 7:15 AM EDT

3 Clean Energy ETFs Up 50% or More: QCLN, LIT, and BATT for the Green Transition in 2026

All three of these ETFs are up more than 50% over the past year, yet they tell very different stories…

Austin Smith | Dec 29, 2025 at 9:47 AM EST

A Battery Supply Chain ETF Quietly Returned 66%, Stomping AI Stocks

While investors fixated on artificial intelligence throughout 2025, the battery supply chain quietly delivered exceptional returns, powering everything from electric…

Amplify Lithium & Battery Technology ETF : BATT

BATT

$16.92

All BATT Articles

3 Clean Energy ETFs Up 50% or More: QCLN, LIT, and BATT for the Green Transition in 2026

A Battery Supply Chain ETF Quietly Returned 66%, Stomping AI Stocks

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Amplify Lithium & Battery Technology ETF : BATT

BATT

$16.92

All BATT Articles

3 Clean Energy ETFs Up 50% or More: QCLN, LIT, and BATT for the Green Transition in 2026

A Battery Supply Chain ETF Quietly Returned 66%, Stomping AI Stocks

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

China’s Semiconductor Equipment Companies Gain Share Despite U.S. Sanctions

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026